Physician profile

Andrew Berdy

Cardiovascular Disease · Belleville, IL

NPI 1821425067

$37,547.36

in general payments reported to CMS, 2019-2025

32 companies · $2,168 in 2025

The $2,168 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,516.75
Travel and Lodging$4,355.30
Education$39.17

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $12,509.79 2020
Abbott Laboratories $8,546.50 2022-2025 Aveir, Ensite, Amplatzer Amulet
Medtronic, INC. $6,731.82 2021-2025 Micra, Linq II, Cobalt Dr Mri Surescan
Boston Scientific Corporation $6,675.18 2019-2025 Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Bodyguardian
Novartis Pharmaceuticals Corporation $443.57 2022-2024
Amgen INC. $407.25 2022-2024 Repatha
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $403.27 2022-2025 Lifevest
Pfizer INC. $261.01 2022-2025
Biotronik INC. $211.87 2021-2024 Amvia Edge, Selectra
Kestra Medical Technology Services, INC. $161.23 2023-2025 Assure Wcd
Lexicon Pharmaceuticals, INC. $113.25 2023-2024 Inpefa
E.R. Squibb & Sons, L.L.C. $99.46 2022-2025 Eliquis
Kiniksa Pharmaceuticals International, Plc $93.97 2024 Arcalyst
Boehringer Ingelheim Pharmaceuticals, INC. $85.08 2022-2024 Jardiance
Irhythm Technologies, INC. $81.84 2024 Zio Monitor, Zio Xt Patch
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $73.70 2023-2024
Chiesi USA, INC. $71.05 2022-2024 Kengreal, Cleviprex
Biosense Webster, INC. $70.66 2025 Carto 3
Janssen Pharmaceuticals, INC $68.34 2022-2024 Xarelto
Merck Sharp & Dohme LLC $63.65 2024 Verquvo
Astrazeneca Pharmaceuticals LP $60.08 2024-2025 Wainua, Brilinta
Shockwave Medical, INC $51.80 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Novo Nordisk INC $44.78 2024-2025 Rybelsus, Ozempic
Cardiva Medical, INC. $44.63 2025 Cardiva Vascade Mvp Xl Vvcs 10-12f
Kiniksa Pharmaceuticals, LTD. $28.00 2023 Arcalyst
Cvrx, INC. $24.60 2025 Barostim Neo System
Zoll Circulation INC $23.78 2025 Downstream Cartridge, Catheter, Therox Ds2 Console
Vital Connect, INC $22.68 2024 Vitalpatch Rtm
Asahi Intecc USA, INC. $20.24 2024 Peripheral Vascular
Heartflow, INC. $19.44 2025
Cordis US Corp. $18.20 2024 Mynx Control
Scpharmaceuticals INC. $16.64 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Andrew Berdy

$37,547.36

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic Vascular, INC.
Context
The $2,168 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/5698123/andrew-berdy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.